News
20487_FP_Header_Newsroom_Website_2400x900px
Corporate, Press release

Dr. Falk Pharma Australia is pleased to announce the 2022 Dr. Falk Pharma-GESA research grant

02. February 2021

Dr. Falk Pharma Australia is pleased to announce the 2022 Dr. Falk Pharma-GESA research grant has been awarded to Dr Scott Nightingale for his planned research titled "food antigen stimulation of esophageal organoids from children with eosinophilic esophagitis – can triggers be identified in vitro?"

Dr Nightingale is a pediatric gastroenterologist and hepatologist emploved as a Senior Staff Specialist at John Hunter Children's Hospital and conducts his research work at the Hunter Medical Research Institute (HMRI). He is also Conjoint Senior Lecturer in Paediatrics and Child Health in the Faculty of Medicine, University of Newcastle.

He completed his subspeciality training at the Children's Hospital

Westmead before undertaking further training in hepatology and liver transplantation medicine at the Hospital for Sick Children, Toronto, Canada. We congratulate Dr Nightingale on being awarded this grant.